Respiratory distress syndrome – Page 4 – Communicable Diseases Research

SARS-CoV-2 triggering autoimmune diseases

자가 면역 질환을 유발하는 SARS-CoV-2

Review

Published on 2022-06-012022-09-11
Journal: Cytokine [Category] COVID19(2023년), MERS, SARS, 유전자 메커니즘, 진단,

Herbal inhibitors of SARS-CoV-2 M pro effectively ameliorate acute lung injury in mice

SARS-CoV-2 M pro의 허브 억제제는 쥐의 급성 폐 손상을 효과적으로 개선합니다

Article

Published on 2022-06-012022-09-11
Journal: Iubmb Life [Category] COVID19(2023년), SARS, 치료제,

[키워드] acute lung injury acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 ALI/ARDS Anti-inflammatory ARDS bacterial lipopolysaccharide cell death China Chinese Compound coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 patients distress effective effective drug effective drugs enzymatic activity functions Herbal identify in vitro in vivo Infectious disease Inhibition assays inhibitors of SARS-CoV-2 lipopolysaccharides Lung injury M pro mice MPro pan-anti-inflammatory protease respiratory distress Respiratory distress syndrome SARS-CoV-2 severe acute respiratory syndrome Coronavirus Spread surface plasmon surface plasmon resonance syndrome the disease Traditional Chinese medicine treating COVID-19 patient Virtual screening virus
[DOI] 10.1002/iub.2616 PMC 바로가기 [Article Type] Article

Mesenchymal stem/stromal cell-based therapies for COVID-19: First iteration of a living systematic review and meta-analysis: MSCs and COVID-19

COVID-19에 대한 중간엽 줄기/기질 세포 기반 치료법: 살아있는 체계적인 검토 및 메타 분석의 첫 번째 반복: MSC 및 COVID-19

Meta-Analysis

Published on 2022-06-012022-09-11
Journal: Cytotherapy [Category] COVID19(2023년), SARS, 치료기술,

[키워드] 95% CI 95% confidence interval acute respiratory distress acute respiratory distress syndrome acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adherence adverse effects Analysis appear case sery Cell Cell-based therapy Clinical outcome Control coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 criteria Critical determine Efficacy Endpoint estimate Exosomes Extracellular Extracellular vesicles Follow-up Future heterogeneity immunomodulatory interleukin-6 ISCT iteration Mesenchymal stem cells Mesenchymal stromal cells Meta-analysis Microvesicles moderate Mortality MSC MSCs nine not performed Other outcome Other outcomes pandemic patients patients with COVID-19 performed Pneumonia potential risk primary analysis random-effect random-effects repeated reported respiratory distress Respiratory distress syndrome risk risk of bia risk of death risk ratio RoB SARS-CoV-2 Secondary outcomes secreted Sepsis severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 standardized mean difference Statistical power stromal cells Study design systematic review therapy for COVID-19 tissue repair treat
[DOI] 10.1016/j.jcyt.2021.12.001 PMC 바로가기 [Article Type] Meta-Analysis

[Acute kidney injury and COVID-19: lung-kidney crosstalk during severe inflammation]

Review

Published on 2022-06-012023-07-09
Journal: Medizinische Klinik, Intensivmedizin Und Notfallme [Category] COVID19(2023년),

[키워드] Artificial respiration Inflammation Respiratory distress syndrome SARS-CoV‑2 Sepsis
[DOI] 10.1007/s00063-022-00919-3 PMC 바로가기 [Article Type] Review

Lung targeted liposomes for treating ARDS

ARDS 치료를 위한 폐 표적 리포솜

Article

Published on 2022-06-012022-09-11
Journal: Journal of controlled release : official journal o [Category] 치료제,

[키워드] accumulate accumulation acute respiratory distress acute respiratory distress syndrome Administered administration alveolar approach ARDS BAL Bronchoalveolar lavage C57BL/6 characterized combined treatment COPD COVID-19 COVID-19 infections cysteine cytokine secretion distal DPPC drug Efficiency encapsulation endotracheal exhibited Gas exchange Hypoxemia IL-1β IL-6 impair infections Inflammation Inflammatory marker inflammatory markers intravenous intravenously lipid composition Lipid nanoparticles lipopolysaccharide Liposome lung lung damage Lung diseases lung disorders lung endothelial lung epithelial Lung inflammation Lungs Macrophage macrophages marker medication Methylprednisolone mice mortality rate mortality rates MPS mucolytic agent Mucus N-acetyl cysteine NAC nanoparticle Nanotechnology nitric oxide outcome Patient penetration provided pulmonary reached reduce reducing Region respiratory respiratory distress Respiratory distress syndrome secretion steroid syndrome therapeutic therapeutic effect therapeutic efficacy TNFα Treatment Treatment outcome were assessed
[DOI] 10.1016/j.jconrel.2022.03.028 PMC 바로가기 [Article Type] Article

Determination of IgG1 and IgG3 SARS-CoV-2 Spike Protein and Nucleocapsid Binding-Who Is Binding Who and Why?

IgG1 및 IgG3 SARS-CoV-2 스파이크 단백질 및 뉴클레오캡시드 결합의 결정 - 누가 누구와 왜 결합합니까?

Article

Published on 2022-05-272022-09-11
Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), MERS, SARS, 진단, 치료법,

[키워드] acute respiratory distress acute respiratory distress syndrome Analysis antibody ARDS bind binding characteristic complement convalescent convalescent patient convalescent plasma COVID-19 cytokine cytokine release demonstrated Determination Differential analysis examined flight Glycation glycosylation humoral immune response IgG IgG1 IgG3 Immunoglobulin implicated indicated infected with SARS-CoV-2 mass spectrometry molecular mechanism nucleocapsid nucleocapsids Pathogenesis plasma samples Predictive predictive profile predominant Protein protein G respiratory distress Respiratory distress syndrome SARS-CoV-2 SARS-COV-2 infection spectral analysis spike Spike protein Spike proteins stimulate syndrome the spike protein thought
[DOI] 10.3390/ijms23116050 PMC 바로가기 [Article Type] Article

Markers of endothelial cell activation are associated with the severity of pulmonary disease in COVID-19

내피 세포 활성화의 마커는 COVID-19에서 폐 질환의 중증도와 관련이 있습니다

Article

Published on 2022-05-192022-09-11
Journal: PLoS ONE [Category] 바이오마커,

[키워드] activate activated Activation acute respiratory distress acute respiratory distress syndrome Antigen association Biomarker Biomarkers biomarkers of inflammation characterized chemokines coronavirus coronavirus disease Coronavirus disease-19 Coronavirus infection correlated COVID-19 cytokine Cytokines D-dimer death endothelial Endothelial cell endothelial cells endothelial injury Factor Hypothesis individual Inflammatory response inflammatory state low-flow oxygen Lung disease mechanical ventilation nasal nasal cannula obstruction oxygen Oxygen requirement Oxygenation participant patients with COVID-19 plasma Plasma levels pro-inflammatory cytokine pro-thrombotic Proinflammatory cytokine proinflammatory cytokines Protein Proteins pulmonary disease released respiratory distress Respiratory distress syndrome selectin severe coronavirus disease severe COVID-19 severity single center Support syndrome tested thrombosis vascular disease vascular inflammation vWF with COVID-19 worsening
[DOI] 10.1371/journal.pone.0268296 PMC 바로가기 [Article Type] Article

Efficacy and Safety of Extracorporeal Membrane Oxygenation in Patients under Mechanical Ventilation with COVID-19 and Severe Acute Respiratory Distress Syndrome: A Health Technology Assessment

COVID-19 및 중증 급성 호흡곤란 증후군으로 기계 환기를 받는 환자의 체외막 산소화 효과 및 안전성: 건강 기술 평가

Review

Published on 2022-05-172022-09-11
Journal: International Journal of Environmental Research an [Category] 임상,

[키워드] acute respiratory distress acute respiratory distress syndrome applied ARDS assessment assessments clinical Clinical practice clinical trial Cochrane Library conducted country COVID-19 critical appraisal Critical care critical care outcomes ECMO Efficacy and safety Evidence Extracorporeal extracorporeal membrane oxygenation Google Health language life LILACS Mechanical mechanical ventilation Mortality observational study organization organizations Patient Quality of life randomized clinical trial registry respiratory respiratory distress Respiratory distress syndrome Safety SARS-CoV-2 screened severe acute respiratory distress syndrome severe ARDS syndrome systematic review technology use of ECMO was performed website were assessed with COVID-19
[DOI] 10.3390/ijerph19106080 PMC 바로가기 [Article Type] Review

Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trial

간질 세포 투여에 의한 급성 호흡 곤란 증후군의 회복(REALIST): 공개 라벨 용량 증량 1상 시험에 이어 무작위, 삼중 맹검, 할당 은폐, 위약 대조 2상 시험을 위한 구조화된 연구 프로토콜

Article

Published on 2022-05-132022-09-11
Journal: Trials [Category] COVID19(2023년), SARS, 임상,

[키워드] 1:1 acute respiratory distress acute respiratory distress syndrome administration allocation ARDS benefit blind causes Cell cells clinical clinical trial Cohort cohort of patient cohorts of patients concealed CONSORT COVID-19 distress dose dose-escalation early stage early stages Efficacy EudraCT Good immunomodulatory incidence include Mesenchymal stem cells Mesenchymal stromal cell Mesenchymal stromal cells moderate to severe MSC MSCs multicentre NHS number Open-label outcome outlined oxygenation index patients patients with moderate Phase 1 phase 1 trial Phase 2 phase 2 trial Placebo placebo-controlled placebo-controlled trial Practice produced protocol randomised rationale receive recruited recruitment repair reported Reporting respiratory distress Respiratory distress syndrome Serious Adverse Events severe ARDS Standard stromal cell stromal cells Study protocol syndrome therapy Trial triple-blind umbilical Umbilical cord
[DOI] 10.1186/s13063-022-06220-0 PMC 바로가기 [Article Type] Article

Repurposing tetracyclines for acute respiratory distress syndrome (ARDS) and severe COVID-19: a critical discussion of recent publications

급성 호흡 곤란 증후군(ARDS) 및 중증 COVID-19에 대한 테트라사이클린 용도 변경: 최근 간행물에 대한 비판적 논의

Article

Published on 2022-05-012022-09-11
Journal: Expert opinion on investigational drugs [Category] COVID19(2023년), SARS, 신약개발,